Company Filing History:
Years Active: 2011-2020
Title: **Antonia Periclou: Innovator in Pharmacological Formulation**
Introduction
Antonia Periclou is a notable inventor based in Jersey City, NJ, recognized for her impactful contributions to pharmaceutical sciences. With three patents to her name, she has developed formulations that improve drug delivery systems, particularly focusing on memantine and related compounds.
Latest Patents
Her most recent patents include innovative formulations designed for enhanced therapeutic efficacy. The first patent, titled "Modified Release Formulations of Memantine Oral Dosage Forms," presents pharmaceutical compositions effective for once-daily administration. This formulation employs a polymeric matrix carrier that sustains drug release between four to 24 hours, ensuring over 80% dissolution within a 6-12 hour window.
The second patent, "Immediate Release Formulations of 1-Aminocyclohexane Compounds, Memantine and Neramexane," pertains to an oral dosage form that provides rapid release of the therapeutic compound. This immediate-release formulation boasts a dissolution rate exceeding 80% within the first 60 minutes and is designed for dose proportionality, supporting both once-daily or twice-daily dosing regimens.
Career Highlights
Antonia is currently associated with Forest Laboratories Holdings Limited, where she continues to push the boundaries of pharmaceutical innovation. Her work significantly contributes to the development of safer, more effective drug delivery systems, demonstrating her commitment to improving patient care.
Collaborations
Throughout her career, Antonia has collaborated with esteemed colleagues, including Niranjan Rao and Wattanaporn Abramowitz. Together, they have focused on advancing research in the realm of pharmacology, contributing to the successful development of new therapeutic solutions.
Conclusion
Through her innovative work and collaboration with fellow researchers, Antonia Periclou stands out as a significant figure in the field of pharmaceutical formulation. Her patents not only underscore her expertise but also highlight her dedication to enhancing the efficacy of treatments available to patients.